The Centers for Medicare and Medicaid Services (CMS) has announced the first 10 drugs chosen for Medicare price negotiation under the Inflation Reduction Act.
Eliquis
Jardiance
Xarelto
Januvia
Farxiga
Entresto
Enbrel
Imbruvica
Stelara
NovoLog
--Developing
0 Comments